Displaying archives for 2016 August:

INVICTAN-2 Clinical Trial for Nonsquamous NSCLC

Posted by Bradley Newton on August 31st, 2016 |

A new clinical trial from Boehringer Ingelheim will be studying the safety and efficacy of a new drug call INVICTAN-2. The drug is similar to the biologic medication Avastin (bevacizumab) which is already approved as a treatment for nonsquamous non-small cell lung cancer.

The Bonnie J. Addario Lung Cancer Foundation Honors Leading Lung Cancer Researcher with the 2016 Addario Lectureship Award

Posted by Bradley Newton on August 5th, 2016 |

The Bonnie J. Addario Lung Cancer Foundation (ALCF) will honor Giorgio Vittorio Scagliotti, M.D., Full Professor of Oncology at University of Torino… Read More